Publication Date:
1997-11-14
Description:
Chemoprevention is the use of pharmacologic or natural agents that inhibit the development of invasive cancer either by blocking the DNA damage that initiates carcinogenesis or by arresting or reversing the progression of premalignant cells in which such damage has already occurred. Recent advances in our understanding of the mechanisms of carcinogenesis have led to the synthesis of new drugs that can inhibit tumor development in experimental animals by selective action on specific molecular targets, such as the estrogen, androgen, and retinoid receptors or inducible cyclooxygenase. Several of these agents (including tamoxifen, 13-cis-retinoic acid, retinyl palmitate, and an acyclic retinoid) are clinically effective in preventing the development of cancer, particularly in patients who are at high risk for developing second primary tumors after surgical removal of the initial tumor.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Hong, W K -- Sporn, M B -- New York, N.Y. -- Science. 1997 Nov 7;278(5340):1073-7.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 80, Houston, TX 77030, USA. whong@notes.mdacc.tmc.edu〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/9353183" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
Anticarcinogenic Agents/*therapeutic use
;
Biomarkers, Tumor/analysis
;
*Chemoprevention
;
Clinical Trials as Topic
;
Drug Therapy, Combination
;
Humans
;
Neoplasm Recurrence, Local/prevention & control
;
Neoplasms/etiology/pathology/*prevention & control
;
Neoplasms, Second Primary/prevention & control
;
Precancerous Conditions/*drug therapy
;
Risk Factors
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
